View Press Releases
-
Profacgen Updates Its Fermentation Process Development Solutions
-
Creative BioMart Unveils Comprehensive Lectin Portfolio for Diverse Research Applications
-
Matexcel Enlarged Its Offerings for Bioglass Products
-
Lifeasible Enhanced Its Plant Metabolite Profiling Services
-
Creative Enzymes Unveils Cutting-edge Homocysteine Methyltransferase, Recombinant for Enhanced Bioprocessing
-
Creative Enzymes Introduces S-Adenosyl-L-Homocysteine Hydrolase, Recombinant
-
IntegrateRNA Unveils Revolutionary Self-Amplifying RNA In Vitro Synthesis Service
-
Creative Proteomics Unleashes the Exosome Untargeted Metabolomics Service
-
Creative Proteomics Uplifts Protein Research with Cutting-Edge Molecular Mass Determination Services
-
Creative Biogene Provides One-stop PEM-Seq Service to Assess Off-target Effect of CRISPR/Cas9
-
Microbialtec Announces Industry-Leading Microbial Identification Services under GMP Standards
-
Creative Proteomics Enhances Proteomics Research with Advanced Post-Translational Modification Analysis Services
-
Samsung Biologics engages suppliers to advance global decarbonization targets
-
Flywheel Collaborates with Microsoft and NVIDIA to Propel End-to-End AI Development Platform on Microsoft Azure
-
Vast Range of Quantum Dots Available at Alfa Chemistry to Foster Innovations in Biotechnology, Optoelectronics, and Catalysis
-
Amerigo Scientific Releases Automated Liquid Handling Equipment to Modernize Pipetting Workflow
Amerigo Scientific launches its innovative automated liquid handling equipment, aimed at modernizing the pipetting workflow within the scientific community.
Nov 26, 2023
-
CD Formulation Provides Efficient Strategies to Develop and Optimize Microspheres & Microneedles
-
PubHive Announces Real-Time Access to Clinical Trial Data
Provides real-time search and access to clinical trial data, enabling researchers to prepare information for certain compounds, synopsis and study design setup and development, and perform clinical document writing.
Nov 26, 2023
-
MemVerge and Sentieon Announce WaveRider for Sentieon to Accelerate Next-Generation Sequencing in the Cloud
MemVerge and Sentieon integrated the world’s most efficient cloud automation platform with the world’s most advanced genomics software engine to form WaveRider for Sentieon. For bioinformaticians and biotech researchers working to reduce cloud costs by accelerating job completion, the WaveRider feature of MemVerge Memory Machine software boosts Sentieon performance by 40%, adding to the 10x performance advantage of Sentieon genomics analytics over open-source alternatives. As part of the collaboration, WaveRider for Sentieon users receive up to 5,000 core hours of Sentieon usage per month free.
Nov 13, 2023
-
Symbiosis Pharmaceutical Services granted MHRA licence following a £1M Investment